Skip to content
PubMed This is a summary of 51 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 51 referenced papers

Top Authors

Geneviève Bernard
McGill University Health Centre
Adeline L. Vanderver
Children's Hospital of Philadelphia
Kether Guerrero
Research Institute of the McGill University Health Centre
Luan T. Tran
Research Institute of the McGill University Health Centre
Nicole I. Wolf
Emma Kinderziekenhuis
Marjo S. van der Knaap
Emma Kinderziekenhuis
Stefanie Perrier
Research Institute of the McGill University Health Centre
Isabelle Thiffault
Children's Mercy Hospital
Enrico Bertini
Bambino Gesù Children's Hospital
Daniela Pohl
University of Ottawa

Top Institutions

Ranked by publications Top 10 institutions
05

Children's Mercy Hospital

Kansas City, United States

12 papers
07

Emory University

Atlanta, United States

9 papers
08

University of Ottawa

Ottawa, Canada

7 papers
Contributors Daniela Pohl
09

Western University

London, Canada

6 papers

References

References (51)
  1. 1

    Neurogenic bladder and neuroendocrine abnormalities in Pol III-related leukodystrophy.

    Potic A, Popovic V, Ostojic J, et al.

    BMC neurology 2015; (15()):22 doi:10.1186/s12883-015-0283-7.

    PMID: 25868523
  2. 2

    Large exonic deletions in POLR3B gene cause POLR3-related leukodystrophy.

    Gutierrez M, Thiffault I, Guerrero K, et al.

    Orphanet journal of rare diseases 2015; (10()):69 doi:10.1186/s13023-015-0279-9.

    PMID: 26045207
  3. 3

    Longitudinal follow up of a boy affected by Pol III-related leukodystrophy: a detailed phenotype description.

    Battini R, Bertelloni S, Astrea G, et al.

    BMC medical genetics 2015; (16()):53 doi:10.1186/s12881-015-0203-0.

    PMID: 26204956
  4. 4

    Genetic heterogeneity in 26 infants with a hypomyelinating leukodystrophy.

    Arai-Ichinoi N, Uematsu M, Sato R, et al.

    Human genetics 2016; (135(1)):89-98 doi:10.1007/s00439-015-1617-7.

    PMID: 26597493
  5. 5

    Diffuse hypomyelination is not obligate for POLR3-related disorders.

    La Piana R, Cayami FK, Tran LT, et al.

    Neurology 2016; (86(17)):1622-6 doi:10.1212/WNL.0000000000002612.

    PMID: 27029625
  6. 6

    [Clinical features and diagnosis of Pelizaeus-Merzbacher disease: five case reports].

    Espinosa E, Mera-Solarte PR, Cote-Orozco JE

    Revista de neurologia 2016; (62(9)):411-4.

    PMID: 27113066
  7. 7

    Hypomorphic mutations in POLR3A are a frequent cause of sporadic and recessive spastic ataxia.

    Minnerop M, Kurzwelly D, Wagner H, et al.

    Brain : a journal of neurology 2017; (140(6)):1561-1578 doi:10.1093/brain/awx095.

    PMID: 28459997
  8. 8

    4H Leukodystrophy: Lessons from 3T Imaging.

    Cayami FK, Bugiani M, Pouwels PJW, et al.

    Neuropediatrics 2018; (49(2)):112-117 doi:10.1055/s-0037-1608780.

    PMID: 29179231
  9. 9

    Hypomyelinating disorders in China: The clinical and genetic heterogeneity in 119 patients.

    Ji H, Li D, Wu Y, et al.

    PloS one 2018; (13(2)):e0188869 doi:10.1371/journal.pone.0188869.

    PMID: 29451896
  10. 10

    A novel homozygous mutation in POLR3A gene causing 4H syndrome: a case report.

    Tewari VV, Mehta R, Sreedhar CM, et al.

    BMC pediatrics 2018; (18(1)):126 doi:10.1186/s12887-018-1108-9.

    PMID: 29618326
  11. 11

    [Hypomyelinating leukodystrophy type 6. Clinical and neuroimaging key features in the detection of a new case].

    Otero-Dominguez E, Gomez-Lado C, Fuentes-Pita P, et al.

    Revista de neurologia 2018; (67(9)):339-342.

    PMID: 30350845
  12. 12

    Dystonia in RNA Polymerase III-Related Leukodystrophy.

    Al Yazidi G, Tran LT, Guerrero K, et al.

    Movement disorders clinical practice 2019; (6(2)):155-159 doi:10.1002/mdc3.12715.

    PMID: 30838315
  13. 13

    Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200.

    Choquet K, Forget D, Meloche E, et al.

    The Journal of biological chemistry 2019; (294(18)):7445-7459 doi:10.1074/jbc.RA118.006271.

    PMID: 30898877
  14. 14

    Novel mutations of the POLR3A gene caused POLR3-related leukodystrophy in a Chinese family: a case report.

    Wu S, Bai Z, Dong X, et al.

    BMC pediatrics 2019; (19(1)):289 doi:10.1186/s12887-019-1656-7.

    PMID: 31438894
  15. 15

    Clinical spectrum of POLR3-related leukodystrophy caused by biallelic POLR1C pathogenic variants.

    Gauquelin L, Cayami FK, Sztriha L, et al.

    Neurology. Genetics 2019; (5(6)):e369 doi:10.1212/NXG.0000000000000369.

    PMID: 32042905
  16. 16

    Identification of a deep intronic POLR3A variant causing inclusion of a pseudoexon derived from an Alu element in Pol III-related leukodystrophy.

    Hiraide T, Nakashima M, Ikeda T, et al.

    Journal of human genetics 2020; (65(10)):921-925 doi:10.1038/s10038-020-0786-y.

    PMID: 32483275
  17. 17

    Estimating the relative frequency of leukodystrophies and recommendations for carrier screening in the era of next-generation sequencing.

    Schmidt JL, Pizzino A, Nicholl J, et al.

    American journal of medical genetics. Part A 2020; (182(8)):1906-1912 doi:10.1002/ajmg.a.61641.

    PMID: 32573057
  18. 18

    Expanding the phenotypic and molecular spectrum of RNA polymerase III-related leukodystrophy.

    Perrier S, Gauquelin L, Fallet-Bianco C, et al.

    Neurology. Genetics 2020; (6(3)):e425 doi:10.1212/NXG.0000000000000425.

    PMID: 32582862
  19. 19

    A novel POLR3A genotype leads to leukodystrophy type-7 in two siblings with unusually late age of onset.

    Campopiano R, Ferese R, Zampatti S, et al.

    BMC neurology 2020; (20(1)):258 doi:10.1186/s12883-020-01835-9.

    PMID: 32600288
  20. 20

    Endocrine and Growth Abnormalities in 4H Leukodystrophy Caused by Variants in POLR3A, POLR3B, and POLR1C.

    Pelletier F, Perrier S, Cayami FK, et al.

    The Journal of clinical endocrinology and metabolism 2021; (106(2)):e660-e674 doi:10.1210/clinem/dgaa700.

    PMID: 33005949
  21. 21

    Neurodevelopmental regression, severe generalized dystonia, and metabolic acidosis caused by POLR3A mutations.

    Zanette V, Reyes A, Johnson M, et al.

    Neurology. Genetics 2020; (6(6)):e521 doi:10.1212/NXG.0000000000000521.

    PMID: 33134517
  22. 22

    Hypomyelination and Congenital Cataract: Three Siblings Presentation.

    Karalok ZS, Gurkasb E, Aydinc K, Ceylaner S

    Journal of pediatric neurosciences 2020; (15(3)):270-273 doi:10.4103/jpn.JPN_161_18.

    PMID: 33531944
  23. 23

    POLR3-Related Leukodystrophy: Exploring Potential Therapeutic Approaches.

    Perrier S, Michell-Robinson MA, Bernard G

    Frontiers in cellular neuroscience 2020; (14()):631802 doi:10.3389/fncel.2020.631802.

    PMID: 33633543
  24. 24

    POLR3-related leukodystrophy: How do mutations affecting RNA polymerase III subunits cause hypomyelination?

    Coulombe B, Derksen A, La Piana R, et al.

    Faculty reviews 2021; (10()):12 doi:10.12703/r/10-12.

    PMID: 33659930
  25. 25

    Case Report: Severe Osteoporosis and Preventive Therapy in RNA Polymerase III-Related Leukodystrophy.

    Furukawa S, Kunii M, Doi H, et al.

    Frontiers in neurology 2021; (12()):622355 doi:10.3389/fneur.2021.622355.

    PMID: 33716926
  26. 26

    Defective myelination in an RNA polymerase III mutant leukodystrophic mouse.

    Merheb E, Cui MH, DuBois JC, et al.

    Proceedings of the National Academy of Sciences of the United States of America 2021; (118(40)) doi:10.1073/pnas.2024378118.

    PMID: 34583988
  27. 27

    Case report: Biallelic variants in POLR3B gene lead to 4H leukodystrophy from the study of brother and sister.

    Bai H, Li D, Zheng Y, Jiang X

    Medicine 2022; (101(34)):e30350 doi:10.1097/MD.0000000000030350.

    PMID: 36042647
  28. 28

    Identification of a Novel Missense Mutation of POLR3A Gene in a Cohort of Sicilian Patients with Leukodystrophy.

    Musumeci A, Calì F, Scuderi C, et al.

    Biomedicines 2022; (10(9)) doi:10.3390/biomedicines10092276.

    PMID: 36140376
  29. 29

    Spectrum of Pediatric to Early Adulthood POLR3A-Associated Movement Disorders.

    Zea Vera A, Bruce A, Larsh TR, et al.

    Movement disorders clinical practice 2023; (10(2)):316-322 doi:10.1002/mdc3.13635.

    PMID: 36825045
  30. 30

    The First Case of 4H Syndrome with Type 1 Diabetes Mellitus

    Büyükyılmaz G, Erozan Çavdarlı B, Toksoy Adıgüzel K, et al.

    Journal of clinical research in pediatric endocrinology 2025; (17(1)):103-108 doi:10.4274/jcrpe.galenos.2023.2023-1-15.

    PMID: 36974356
  31. 31

    A novel variant of the POLR3A gene in a Chinese patient with POLR3-related leukodystrophy.

    Yang H, Wu Z, Li X, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2023; (44(9)):3363-3368 doi:10.1007/s10072-023-06767-z.

    PMID: 36988728
  32. 32

    Decreased RNA polymerase III subunit expression leads to defects in oligodendrocyte development.

    Macintosh J, Michell-Robinson M, Chen X, Bernard G

    Frontiers in neuroscience 2023; (17()):1167047 doi:10.3389/fnins.2023.1167047.

    PMID: 37179550
  33. 33

    Uncertain significance mutation in the POLR3B gene in a Syrian boy with leukodystrophy: a case report.

    Hamdan Z, Alasmar D

    Annals of medicine and surgery (2012) 2023; (85(8)):4126-4130 doi:10.1097/MS9.0000000000001033.

    PMID: 37554900
  34. 34

    Biallelic pathogenic variants in POLR3D alter tRNA transcription and cause a hypomyelinating leukodystrophy: A case report.

    Macintosh J, Perrier S, Pinard M, et al.

    Frontiers in neurology 2023; (14()):1254140 doi:10.3389/fneur.2023.1254140.

    PMID: 37915380
  35. 35

    A Chinese patient with POLR3A-related leukodystrophy: a case report and literature review.

    Sun L, Lin W, Meng H, et al.

    Frontiers in neurology 2023; (14()):1269237 doi:10.3389/fneur.2023.1269237.

    PMID: 37965164
  36. 36

    Case report: Neuropsychological assessment in a patient with 4H leukodystrophy.

    Haneda A, Hoots JK, Hagy HA, Lacy M

    The Clinical neuropsychologist 2024; (38(5)):1272-1289 doi:10.1080/13854046.2023.2279697.

    PMID: 37974060
  37. 37

    POLR3-related leukodystrophy caused by biallelic POLR3A and 1C pathogenic variants: a single-center experience.

    Liu J, Niu Y, Qin J, Yang Z

    Frontiers in neurology 2024; (15()):1355484 doi:10.3389/fneur.2024.1355484.

    PMID: 38550343
  38. 38

    POLR3A-related disorders: From spastic ataxia to generalised dystonia and long-term efficacy of deep brain stimulation.

    Yau WY, Ashton C, Mulroy E, et al.

    Annals of clinical and translational neurology 2024; (11(6)):1636-1642 doi:10.1002/acn3.52064.

    PMID: 38700104
  39. 39

    Inherited white matter disorders: Hypomyelination (myelin disorders).

    Perrier S, Gauquelin L, Bernard G

    Handbook of clinical neurology 2024; (204()):197-223 doi:10.1016/B978-0-323-99209-1.00014-4.

    PMID: 39322379
  40. 40

    Stress and Quality of Life of Parents of Children With POLR3-Related Leukodystrophy: A Cross-Sectional Pilot Study.

    Lentini L, Toutounchi H, Chapleau A, et al.

    Journal of child neurology 2025; (40(1)):26-38 doi:10.1177/08830738241283171.

    PMID: 39429022
  41. 41

    Tremor Ataxia With Central Hypomyelation Phenotype Related to a Recurrent POLR3A Mutation in Six Unrelated Tunisian Families.

    Kraoua I, Jamoussi M, Drissi C, et al.

    Molecular genetics & genomic medicine 2024; (12(10)):e70007 doi:10.1002/mgg3.70007.

    PMID: 39436788
  42. 42

    Molecular basis of neurodegeneration in a mouse model of Polr3-related disease.

    Moir RD, Merheb E, Chitu V, et al.

    eLife 2024; (13()).

    PMID: 39499645
  43. 43

    Endocrine Care of a 19-year-old Woman With Isolated Hypogonadotropic Hypogonadism due to 4H Syndrome.

    Nwatamole B, Kundu S, Odukudu GO, et al.

    AACE clinical case reports 2024; (10(6)):229-231 doi:10.1016/j.aace.2024.08.001.

    PMID: 39734507
  44. 44

    Neuropsychological profile of POLR3A-related spastic ataxia.

    Cypers G, Delaruelle Z, den Stock JV

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2025; (46(3)):1383-1387 doi:10.1007/s10072-024-07884-z.

    PMID: 39739274
  45. 45

    POLR3-Related Leukodystrophy: A Qualitative Study on Parents' Experiences With the Health Care System.

    Le A, Thibault KA, Yazdani PA, et al.

    Pediatric neurology 2025; (166()):81-87 doi:10.1016/j.pediatrneurol.2025.02.011.

    PMID: 40106878
  46. 46

    POLR3-Related Leukodystrophy: A Case Series from the Indian Scenario.

    Meena AK, Wander A, Mahesan A, et al.

    Neurology India 2025; (73(2)):325-329 doi:10.4103/neurol-india.Neurol-India-D-24-00198.

    PMID: 40176224
  47. 47

    Novel Pathogenic Variants in POLR3K Cause POLR3-Related Leukodystrophy.

    Perrier S, Macintosh J, Misiaszek AD, et al.

    Human mutation 2024; (2024()):8807171 doi:10.1155/2024/8807171.

    PMID: 40225923
  48. 48

    "Deep Brain Stimulation of the Ventral Intermediate Nucleus of the Thalamus for Tremor in Polr3a-Related Tremor-ataxia Syndrome: A Two-case Report".

    Sánchez-Román EJ, Villa-Villegas L, Leal-Ortega R, et al.

    Tremor and other hyperkinetic movements (New York, N.Y.) 2025; (15()):42 doi:10.5334/tohm.1000.

    PMID: 40917817
  49. 49

    POLR3B-Related Hypomyelinating Leukodystrophy Type 8 (4H Syndrome): A Case Series of Two Siblings.

    Mani Jacob D, Nagarajan DR, Kakade SJ

    Cureus 2025; (17(8)):e90642 doi:10.7759/cureus.90642.

    PMID: 40978896
  50. 50

    The Impact of RNA Polymerase III-Related Leukodystrophy on Nonaffected Family Members: A Qualitative Study.

    Le A, Thibault KA, Yazdani PA, et al.

    Pediatric neurology 2026; (176()):31-40 doi:10.1016/j.pediatrneurol.2025.12.004.

    PMID: 41518854
  51. 51

    Performance outcomes of the PEDI-CAT for assessing functional ability in the population with leukodystrophy.

    Cusack SV, Glanzman AM, Gavazzi F, et al.

    Developmental medicine and child neurology 2026; doi:10.1111/dmcn.70299.

    PMID: 42060827